Insufficient Bone Mass in the Maxilla for Dental ImplantsPhase 1DKK SVPNCT01204424
Clinical Investigation to Assess the Safety and Feasibility of the Crestal, Minimal-invasive Sinus Floor Augmentation With the Pressure Chamber Drill (DKK) and the Sinus Vibration Pump (SVP)
A Phase 1 study testing minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.) and minimal invasive crestal sinus lift with the JEDER Systh. in people with Insufficient Bone Mass in the Maxilla for Dental Implants, run by Jeder GmbH at 1 site in Austria.
Trial summary
The success of dental implants is based on a variety of factors including; surgical technique, health of the patient, operator skill and, to a significant part, sufficient bone for the placement and integration of dental implants. Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Insufficient Bone Mass in the Maxilla for Dental Implants
- What is being tested?
- minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.) and minimal invasive crestal sinus lift with the JEDER Systh.
- Type of treatment
- Medical device
- How many people
- 20 participants
- Where
- 1 siteAustria
- Study dates
- Sep 2010to Jun 2011
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- demand for sinus floor elevation (regio 4 to 7)
- loss of teeth (regio 4 to 7)
- needed extraction of teeth (regio 4 to 7)
Who cannot join
- maxillary bone mass <3mm
- severe chronic illness or immune deficiency
- cortisone therapy
- sinus membrane membrane hight >5mm
- chronic sinusitis
- smoking >20 Zigarettes
- missing dental hygiene
Trial locations and contacts
1 site in 1 country.
Andreas Bayerle, MBA contact
Michaela Bayerle-Eder, Prof., contact
Austria1 site, 1 recruiting
- Recruiting
Ordination Dr. Klaus Eder
Vienna, State of Vienna, 1130
About this study
Official title: Klinische Prüfung Zur Untersuchung Der Sicherheit Und Machbarkeit Des Crestalen, Minimal-invasiven Kieferknochenaufbaus (Sinuslift) Mit Der Druck-kammerknochenfräse (DDK) Und Der Sinusvibrationspumpe (SVP)
The success of dental implants is based on a variety of factors including; surgical technique, health of the patient, operator skill and, to a significant part, sufficient bone for the placement and integration of dental implants. To that end, the replacement of the maxillary posterior teeth have presented a considerable challenge because, after the loss of maxillary posterior teeth the quality and quantity of the remaining supporting bone may be insufficient to support implants properly or reliably. To overcome the deficiency of insufficient vertical bone mass of the maxilla, several surgical techniques have been developed to increase available bone mass for the replacement of dental implants by bone augmentation.
The conventional procedure for a sinus lift (Caldwell-Luc procedure) requires preparation of a mucoperiosteal flap in the buccal molar region and to cut an oval window in the thus exposed bone, without damage to the subjacent maxillary sinus membrane. The procedure is very invasive and subjects the patient to great stress as a result of substantial swelling and discoloration of up to 10 days, and possibly of pain. This surgical procedure is oftentimes referred to as "open" or "classic" sinus lift. This technique is fraught with many risks and complications because of the limitations of healing potential in the maxillary sinus. In spite of these risks many patients undergo this procedure because of the strong desire to replace missing maxillary teeth with dental implants.
Read more
An alternative approach to the maxillary sinus from the inferior approach of the alveolar ridge utilizing solid cylindrical osteotomes was described by Dr. Summers (crestal sinus lift). It is a more conservative approach and is less invasive. It was developed to eliminate the risks described above.While this technique is safer, an overzealous use of an osteotome during the placement of the regenerative material can result in the perforation of the subantral membrane with disadvantages discussed above.
Dr. Eder has developed an innovative way - the JEDER System - of carrying out a crestal sinus lift that substantially reduces the risk of perforating the subantral membrane. This minimal- invasive way uses 2 newly developed and successfully patented instruments, the "Druckkammerknochenfräse" DKK and the "Sinusvibrationspumpe" SVP. Following JEDER Syst. the mucous membrane of the mouth is opened from the toothless part of the maxillary crest up to the bone and the bone is scraped by a cylindrical cutter in the shape of a tunnel up to slightly underneath the maxillary sinus membrane.
The aim of the study is to assess the efficacy and safety of the JEDER Syst., which was already demonstrated in 50 treatment attempts. The results of this study will be used for the certification process to enable the declaration of conformity for the market approval.
The main outcome parameter is the perforation rate of the subantral membrane intraoperatively and within 6 weeks after the operation.
Risk benefit assessment:
In the present study there will be no additional examinations undertaken compared to patients which undergo the conventional procedure. The conventional procedure is associated with a risk of membrane perforation and consecutive diseases like infection, swelling and pain. All these inconveniences should be avoided by using the JEDER Syst. If the worst case scenario - the perforation of the subantral membrane - happens, the conventional method will be used. Therefore, the risk-benefit assessment
- Being tested
- minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.), minimal invasive crestal sinus lift with the JEDER Systh.
- Keywords
- minimal invasive, sinus floor augmentation, sinuslift, dental implants
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.)Device
minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.)
minimal invasive crestal sinus lift with the JEDER Systh.Device
Also called minimal invasive crestal sinuslift
The mucous membrane is opened from the toothless part of the maxillary crest up to the bone and the bone is scraped by a cylindrical cutter in the shape of a tunnel up to slightly underneath the maxillary sinus membrane and hydraulic pressure is being built up within the DKK. A centrally placed drill within the DKK slowly moves in the direction of the membrane. At the moment of the first minimal perforation of the remaining bone the pressurized fluid pushes the membrane back and ensures that the membrane is not perforated by the drill.
The SVP is used to generate hydraulic vibrations, which help to further raise the membrane from the bone (principle of the "percussion drill"). After the maxillary sinus membrane has successfully been elevated, the working fluid is extracted and bone replacement material is introduced via the bore.
What is being measured
The primary outcome is the main question the study is designed to answer.
perforation rate of the subantral membrane in the sinus maxillaris
Measured: intraoperativ and within 6 weeks after the operation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Sep 2010 (estimated)
- Study startSep 2010
- Primary completionMar 2011 (estimated)
- Study completionJun 2011 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Insufficient Bone Mass in the Maxilla for Dental ImplantsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Jeder GmbH
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Michaela M Bayerle-Eder, Prof., MD, MBA, Study director, Medical University Vienna, Vienna Austria, Europe
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01204424
- Sponsor's protocol ID
- DKK-SVP-10 Prot. 1.4
- Other IDs
- EK_10_101_0610
- Acronym
- DKK SVP
- Status last verified
- Sep 2010
- First submitted
- 16 Sep 2010
- Last updated
- 17 Sep 2010
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 17 Sep 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Klinische Prüfung Zur Untersuchung Der Sicherheit Und Machbarkeit Des Crestalen, Minimal-invasiven Kieferknochenaufbaus (Sinuslift) Mit Der Druck-kammerknochenfräse (DDK) Und Der Sinusvibrationspumpe (SVP)
- ClinicalTrials.gov ID
- NCT01204424
- Acronym / sponsor ID
- DKK SVP / DKK-SVP-10 Prot. 1.4
- Keywords
- minimal invasive, sinus floor augmentation, sinuslift, dental implants
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Jeder GmbHIndustry (pharma, biotech, devices)
- Study start
- Sep 2010
- Primary completion
- Mar 2011 (estimated)
- Study completion
- Jun 2011 (estimated)
- First posted
- 17 Sep 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The success of dental implants is based on a variety of factors including; surgical technique, health of the patient, operator skill and, to a significant part, sufficient bone for the placement and integration of dental implants. To that end, the replacement of the maxillary posterior teeth have presented a considerable challenge because, after the loss of maxillary posterior teeth the quality and quantity of the remaining supporting bone may be insufficient to support implants properly or reliably. To overcome the deficiency of insufficient vertical bone mass of the maxilla, several surgical techniques have been developed to increase available bone mass for the replacement of dental implants by bone augmentation.
The conventional procedure for a sinus lift (Caldwell-Luc procedure) requires preparation of a mucoperiosteal flap in the buccal molar region and to cut an oval window in the thus exposed bone, without damage to the subjacent maxillary sinus membrane. The procedure is very invasive and subjects the patient to great stress as a result of substantial swelling and discoloration of up to 10 days, and possibly of pain. This surgical procedure is oftentimes referred to as "open" or "classic" sinus lift. This technique is fraught with many risks and complications because of the limitations of healing potential in the maxillary sinus. In spite of these risks many patients undergo this procedure because of the strong desire to replace missing maxillary teeth with dental implants.
An alternative approach to the maxillary sinus from the inferior approach of the alveolar ridge utilizing solid cylindrical osteotomes was described by Dr. Summers (crestal sinus lift). It is a more conservative approach and is less invasive. It was developed to eliminate the risks described above.While this technique is safer, an overzealous use of an osteotome during the placement of the regenerative material can result in the perforation of the subantral membrane with disadvantages discussed above.
Dr. Eder has developed an innovative way - the JEDER System - of carrying out a crestal sinus lift that substantially reduces the risk of perforating the subantral membrane. This minimal- invasive way uses 2 newly developed and successfully patented instruments, the "Druckkammerknochenfräse" DKK and the "Sinusvibrationspumpe" SVP. Following JEDER Syst. the mucous membrane of the mouth is opened from the toothless part of the maxillary crest up to the bone and the bone is scraped by a cylindrical cutter in the shape of a tunnel up to slightly underneath the maxillary sinus membrane.
The aim of the study is to assess the efficacy and safety of the JEDER Syst., which was already demonstrated in 50 treatment attempts. The results of this study will be used for the certification process to enable the declaration of conformity for the market approval.
The main outcome parameter is the perforation rate of the subantral membrane intraoperatively and within 6 weeks after the operation.
Risk benefit assessment:
In the present study there will be no additional examinations undertaken compared to patients which undergo the conventional procedure. The conventional procedure is associated with a risk of membrane perforation and consecutive diseases like infection, swelling and pain. All these inconveniences should be avoided by using the JEDER Syst. If the worst case scenario - the perforation of the subantral membrane - happens, the conventional method will be used. Therefore, the risk-benefit assessment
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- demand for sinus floor elevation (regio 4 to 7)
- loss of teeth (regio 4 to 7)
- needed extraction of teeth (regio 4 to 7)
Key exclusion criteria (7 listed)
- maxillary bone mass <3mm
- severe chronic illness or immune deficiency
- cortisone therapy
- sinus membrane membrane hight >5mm
- chronic sinusitis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.)minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.) | Device | – |
| minimal invasive crestal sinus lift with the JEDER Systh.Also: minimal invasive crestal sinusliftThe mucous membrane is opened from the toothless part of the maxillary crest up to the bone and the bone is scraped by a cylindrical cutter in the shape of a tunnel up to slightly underneath the maxillary sinus membrane and hydraulic pressure is being built up within the DKK. A centrally placed drill within the DKK slowly moves in the direction of the membrane. At the moment of the first minimal perforation of the remaining bone the pressurized fluid pushes the membrane back and ensures that the membrane is not perforated by the drill. The SVP is used to generate hydraulic vibrations, which help to further raise the membrane from the bone (principle of the "percussion drill"). After the maxillary sinus membrane has successfully been elevated, the working fluid is extracted and bone replacement material is introduced via the bore. | Device | – |
Primary outcome
perforation rate of the subantral membrane in the sinus maxillaris
Time frame: intraoperativ and within 6 weeks after the operation
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Sep 2010.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andreas Bayerle, MBA contact
Michaela Bayerle-Eder, Prof., contact
Michaela M Bayerle-Eder, Prof., MD, MBA study director
Medical University Vienna, Vienna Austria, Europe
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.) and minimal invasive crestal sinus lift with the JEDER Systh. in people with Insufficient Bone Mass in the Maxilla for Dental Implants, run by Jeder GmbH at 1 site in Austria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 17 Sep 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Andreas Bayerle, MBA (abayerle@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
perforation rate of the subantral membrane in the sinus maxillaris (time frame: intraoperativ and within 6 weeks after the operation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2010; AzTrials last refreshed its copy on 8 Nov 2026.